Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07119398 · ClinicalTrials.gov registry record · Phase 4
Oxytocin/Foley vs. Oxytocin for Induction in Patients With PPROM
A Phase 4 study of Preterm PROM (Pregnancy), sponsored by Eastern Virginia Medical School.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT07119398 is a Phase 4 study of Preterm PROM (Pregnancy) that is actively recruiting participants, run by Eastern Virginia Medical School. The registered enrollment target is 80 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07119398, a Phase 4 study of Preterm PROM (Pregnancy), is actively recruiting participants, sponsored by Eastern Virginia Medical School.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Data on the optimal mode of labor induction after preterm prelabor rupture of membranes (PPROM) is lacking. Studies have shown no difference between oxytocin and misoprostol use for labor induction in this cohort (1). The preponderance of evidence from term pregnancies suggests that Foley catheter coupled with oxytocin is better than oxytocin alone, with a higher rate of delivery within 24 hours when a Foley catheter followed by oxytocin is compared to oxytocin alone. However, the use of a Foley catheter has not been evaluated in prospective studies on patients with PPROM.
Conditions Studied
Interventions
- COMBINATION_PRODUCT Oxytocin plus Foley Catheter
- DRUG Oxytocin
Study Locations (1)
Virginia
- Sentara Norfolk General Hospital - Norfolk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-07-14 |
| Est. Completion | 2026-12-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07119398
The ClinicalTrials.gov registry entry for NCT07119398 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eastern Virginia Medical School, which has 36 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Preterm PROM (Pregnancy) appearing as the primary indexed condition, and to 2 interventions - of which Oxytocin plus Foley Catheter is the first listed.
NCT07119398 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT07119398 about?
NCT07119398 is a clinical study titled "Oxytocin/Foley vs. Oxytocin for Induction in Patients With PPROM". Data on the optimal mode of labor induction after preterm prelabor rupture of membranes (PPROM) is lacking. Studies have shown no difference between oxytocin and misoprostol use for labor induction in this cohort (1). The preponderance of evidence from term pregnancies suggests that Foley catheter c...
What is the current status of trial NCT07119398?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2025-07-14. Estimated completion is 2026-12-30.
What conditions does trial NCT07119398 study?
This clinical trial studies the following conditions: Preterm PROM (Pregnancy).
What interventions are being tested in trial NCT07119398?
The interventions under investigation include: Oxytocin plus Foley Catheter (COMBINATION_PRODUCT), Oxytocin (DRUG).
Who is sponsoring clinical trial NCT07119398?
This trial is sponsored by Eastern Virginia Medical School, which has 36 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07119398 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preterm PROM (Pregnancy)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.